Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

The association between diabetes, level of glycaemic control and eye infection: Cohort database study.

Ansari AS, de Lusignan S, Hinton W, Munro N, McGovern A.

Prim Care Diabetes. 2017 Oct;11(5):421-429. doi: 10.1016/j.pcd.2017.05.009. Epub 2017 Jun 23.

PMID:
28648963
2.

Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study.

Hine JL, de Lusignan S, Burleigh D, Pathirannehelage S, McGovern A, Gatenby P, Jones S, Jiang D, Williams J, Elliot AJ, Smith GE, Brownrigg J, Hinchliffe R, Munro N.

Diabet Med. 2017 Apr;34(4):551-557. doi: 10.1111/dme.13205. Epub 2016 Sep 22.

PMID:
27548909
3.

Glycemic control is an important modifiable risk factor for uveitis in patients with diabetes: A retrospective cohort study establishing clinical risk and ophthalmic disease burden.

Ansari AS, de Lusignan S, Hinton W, Munro N, Taylor S, McGovern A.

J Diabetes Complications. 2018 Jun;32(6):602-608. doi: 10.1016/j.jdiacomp.2018.03.008. Epub 2018 Mar 23.

PMID:
29656910
4.

Safety of non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: A cohort study.

Cea-Soriano L, García-Rodríguez LA, Brodovicz KG, Masso Gonzalez E, Bartels DB, Hernández-Díaz S.

Diabetes Obes Metab. 2018 Jul;20(7):1642-1651. doi: 10.1111/dom.13275. Epub 2018 Mar 26.

PMID:
29498473
5.

Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.

Ajjan RA, Abougila K, Bellary S, Collier A, Franke B, Jude EB, Rayman G, Robinson A, Singh BM.

Diab Vasc Dis Res. 2016 May;13(3):211-9. doi: 10.1177/1479164115624680. Epub 2016 Mar 21.

PMID:
27000105
7.

Is Helicobacter pylori infection associated with glycemic control in diabetics?

Dai YN, Yu WL, Zhu HT, Ding JX, Yu CH, Li YM.

World J Gastroenterol. 2015 May 7;21(17):5407-16. doi: 10.3748/wjg.v21.i17.5407. Review.

8.

Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.

Matuleviciene-Anängen V, Rosengren A, Svensson AM, Pivodic A, Gudbjörnsdottir S, Wedel H, Kosiborod M, Haraldsson B, Lind M.

Heart. 2017 Nov;103(21):1687-1695. doi: 10.1136/heartjnl-2016-311050. Epub 2017 Jul 14.

PMID:
28710186
9.

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes.

Paul SK, Klein K, Thorsted BL, Wolden ML, Khunti K.

Cardiovasc Diabetol. 2015 Aug 7;14:100. doi: 10.1186/s12933-015-0260-x.

10.

Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses.

Rathmann W, Pscherer S, Konrad M, Kostev K.

Prim Care Diabetes. 2016 Feb;10(1):36-40. doi: 10.1016/j.pcd.2015.04.001. Epub 2015 Apr 27.

PMID:
25937183
11.

Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up.

Wilding J, Bailey C, Rigney U, Blak B, Kok M, Emmas C.

Prim Care Diabetes. 2017 Oct;11(5):437-444. doi: 10.1016/j.pcd.2017.04.004. Epub 2017 Jun 2.

PMID:
28583425
12.

Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus.

Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N, Wan Ngah WZ.

Int J Clin Pharm. 2012 Dec;34(6):863-70. doi: 10.1007/s11096-012-9682-7. Epub 2012 Aug 7.

PMID:
22869200
13.

Gaps and barriers in the control of blood glucose in people with type 2 diabetes.

Blonde L, Aschner P, Bailey C, Ji L, Leiter LA, Matthaei S; Global Partnership for Effective Diabetes Management.

Diab Vasc Dis Res. 2017 May;14(3):172-183. doi: 10.1177/1479164116679775. Epub 2017 Feb 1. Review.

14.

Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study.

Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG.

Diabetes Care. 2018 Oct;41(10):2127-2135. doi: 10.2337/dc18-0287. Epub 2018 Aug 13.

PMID:
30104296
15.

Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0-29 years: The population-based CINECA-SID ARNO Observatory, 2002-2012.

Bruno G, Pagano E, Rossi E, Cataudella S, De Rosa M, Marchesini G, Miccoli R, Vaccaro O, Bonora E.

Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1104-1111. doi: 10.1016/j.numecd.2016.09.002. Epub 2016 Sep 20.

16.

Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.

Bruderer SG, Bodmer M, Jick SS, Bader G, Schlienger RG, Meier CR.

Diabetes Obes Metab. 2014 Sep;16(9):801-11. doi: 10.1111/dom.12282. Epub 2014 Mar 19.

PMID:
24612200
17.

Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.

Wang SY, Andrews CA, Herman WH, Gardner TW, Stein JD.

Ophthalmology. 2017 Apr;124(4):424-430. doi: 10.1016/j.ophtha.2016.10.031. Epub 2016 Nov 30.

18.

Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus.

Chang YL, Sheu WH, Lin SY, Liou WS.

Clin Exp Med. 2018 Aug;18(3):383-390. doi: 10.1007/s10238-018-0497-2. Epub 2018 Mar 23.

PMID:
29572669
19.

The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study.

Lycett D, Nichols L, Ryan R, Farley A, Roalfe A, Mohammed MA, Szatkowski L, Coleman T, Morris R, Farmer A, Aveyard P.

Lancet Diabetes Endocrinol. 2015 Jun;3(6):423-430. doi: 10.1016/S2213-8587(15)00082-0. Epub 2015 Apr 29.

PMID:
25935880
20.

Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study.

Svensson E, Baggesen LM, Thomsen RW, Lyngaa T, Pedersen L, Nørrelund H, Buhl ES, Haase CL, Johnsen SP.

Diabet Med. 2016 Nov;33(11):1516-1523. doi: 10.1111/dme.13184. Epub 2016 Jul 31.

PMID:
27412570

Supplemental Content

Support Center